Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from AstraZeneca Pharma India Limited ( (IN:ASTRAZEN) ).
AstraZeneca Pharma India Limited has announced that ordinary resolutions seeking shareholder approval for material related-party transactions have been passed by non-related members through a postal ballot, with the requisite majority. The company has filed the scrutinizer’s report and detailed voting results with the stock exchanges and published them on its website and the National Securities Depository Limited portal, formalizing shareholder consent for these transactions and reinforcing its compliance with SEBI disclosure norms.
More about AstraZeneca Pharma India Limited
AstraZeneca Pharma India Limited operates in the pharmaceutical industry, focusing on the development, manufacturing and marketing of prescription medicines across key therapeutic areas. The company serves the Indian healthcare market as part of the global AstraZeneca group, supplying innovative treatments to hospitals, clinics and patients nationwide.
Average Trading Volume: 518
Technical Sentiment Signal: Buy
Current Market Cap: 194B INR
See more data about ASTRAZEN stock on TipRanks’ Stock Analysis page.